2</sub>) 及血清CXCL1O、CX3CL1水平明顯降低 P<0.01 );且觀察組中的上述指標(biāo)明顯低于對(duì)照組 (P<0.01 )。與治療前相比,治療后兩組動(dòng)脈血氧分壓 (PaO<sub>2</sub>) 第1秒用力呼氣容積與用力肺活量比值(FEV/FVC) FEV<sub>1</sub> 占預(yù)計(jì)值百分比 FEV<sub>1</sub>%pred ) 、6MWD 明顯升高( P<0.01 ;且觀察組中的上述指標(biāo)明顯高于對(duì)照組 (P<0.01) )。治療期間,兩組均未出現(xiàn)明顯不良事件。結(jié)論AECOPD痰濁阻肺證患者采用二陳湯合六君子湯化裁治療,可緩解臨床癥狀,改善肺通氣功能,提高生活質(zhì)量,降低血清CXCL10、CX3CL1水平,效果顯著,且安全性高。-龍?jiān)雌诳W(wǎng)" />

特黄三级爱爱视频|国产1区2区强奸|舌L子伦熟妇aV|日韩美腿激情一区|6月丁香综合久久|一级毛片免费试看|在线黄色电影免费|国产主播自拍一区|99精品热爱视频|亚洲黄色先锋一区

二陳湯合六君子湯化裁聯(lián)合常規(guī)西醫(yī)治療慢性阻塞性肺疾病急性加重期療效觀察

  • 打印
  • 收藏
收藏成功


打開文本圖片集

本文引用:,.二陳湯合六君子湯化裁聯(lián)合常規(guī)西醫(yī)治療慢性阻塞性肺疾病急性加重期療效觀察[].·湖南中醫(yī)藥大學(xué)學(xué)報(bào),2025,45(5):904-909.

[關(guān)鍵詞]二陳湯;六君子湯;慢性阻塞性肺疾病急性加重期;痰濁阻肺證;療效;趨化因子 [中圖分類號(hào)]R256.1 [文獻(xiàn)標(biāo)志碼]B [文章編號(hào)]doi:10.3969/j.issn.1674-070X.2025.05.017

[Abstract]Objective Toexplore theeficacyof modifiedErchenDecoctionandLiujunziDecoctioncombined with conventional western medicine therapyintreatingacuteexacerbationof chronicobstructive pulmonarydisease (AECOPD)(phlegm dampnessaccmulating inthe lungpatern). Methods Atotalof136AECOPDpatients with phlegmdampnessaccumulatinginthe lungpaternadmitedtotheEighthPeoplesHospitalofHefeifromJanuary2022toJanuary2O24wereselectedandrandomly dividedintoobservationgroupandcontrolgroup.Thecontrolgroupreceivedconventionalwesternmedicinetherapy,whilethe observationgroupreceivedoraladministrationofmodifiedErchenDecoctionandLiujunziDecoctioninadition tothetreatment provided tothecontrolgoup ClicaleficacyTCMpatensoresbloodasparameters,lungfunctioindicatorsCOPAe Test (CAT scores,6-minutewalkingdistance (6MWD),serumlevelsof CX chemokineligand1(CXCL10)andCX3chemokineligand 1(CX3CL1) beforeandaftertreatment werecomparedbetweenthetwo groups,andthesafetyof medication wasanalyzeda well Results The total effctive rate of the observation group was higher than that of the control group ( P- <0.01).Compared with before treatment,TCMpattrnscores,CATscoresarterialpartialpresureofcarbondioxide(aCO),andserum levelsof CXCLnd CX3CL1 decreased in both groups after treatment ( P- forced expiratory volume in one second to forced vital capacity (FEV/FVC) ratio, FEV1 to the predicted value (FEVi%pred),and 6MWDaftertreatment(POO1),andtheaboveindicatorsintheobservation groupwerehigherthanthoseinthecontrol group(001). Duringtreatment,noobviousadverseeventsocured ineither group.ConclusionForAECOPDpatientswith phlegmdampness accumulatinginthelungpatern,thetreatment withmodifiedErchenDecoctionandLiujunzi Decoctioncanrelieveclinical symptoms,improvepulmonaryventilation function,enhancethequalityof life,andreduce theserum levelsofCXCL10and CX3CL1, exhibiting significant efficacy and high safety.

[Keywords]Erchen Decoction;Liujunzi Decoction;acuteexacerbation of chronic obstructive pulmonarydisease;phlegm dampness accumulating in the lung pattern; therapeutic effct; chemokine

慢性阻塞性肺疾?。╟hronicobstructivepulmonarydisease,COPD)是常見呼吸系統(tǒng)疾病,研究數(shù)據(jù)顯示,我國(guó)COPD患病人數(shù)接近1億。(剩余8568字)

目錄
monitor